Dr Alistair Vickery

Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.

Medical Director: Emerald Clinics

Drive Change Update on NSW Drug Driving Laws

Statement by Cate Faehrmann MLC “On Wednesday 19 March 2025, I secured the support of the NSW Legislative Council calling on NSW Police, NSW Health and other relevant government agencies to release all data relating to mobile drug testing and medicinal cannabis. There is currently a distinct lack of available data and information to assess […]

Reform for Roadside Drug Testing in NSW

This report provides an overview of recent data provided to the Legislative Council by the Minister for Police and Counter-terrorism in New South Wales on 10 September 2024, with regards to roadside drug tests conducted over the last 5 years (by Local Area Command), number of positives by drug type and whether there has been […]